
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Rehmannia glutinosa is a Traditional Chinese Medicine root containing catalpol and rehmannioside compounds that support kidney function and blood circulation. The herb's steamed form (Shu Di Huang) tonifies kidney yin energy and may enhance adrenal health through hypothalamic-pituitary-adrenal axis modulation.

Reported Benefits (Provisional)
Origin & History

Rehmannia Glutinosa, also known as Shu Di Huang, is a root native to China. It is traditionally steamed and dried to enhance its therapeutic properties, often used in herbal decoctions.
Research Narrative (Provisional)
Animal studies support rehmannia's anti-inflammatory and immune-boosting effects. Limited human trials suggest potential benefits in kidney health and anemia management.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Rich in iridoid glycosides and polysaccharides. - Contains vitamins A and C. - Provides essential minerals like calcium and magnesium.
Reported Mechanism (Provisional)
Rehmannia glutinosa's primary bioactive compound catalpol activates the PI3K/Akt signaling pathway, promoting cellular survival and reducing oxidative stress in kidney tissues. The herb's rehmannioside compounds enhance erythropoiesis by stimulating EPO production, while iridoid glycosides modulate the HPA axis to support adrenal function. Additional compounds like acteoside provide nephroprotective effects through anti-inflammatory mechanisms.
Clinical Narrative (Provisional)
Limited human studies exist for rehmannia glutinosa as a standalone ingredient, with most research conducted in animal models or as part of Traditional Chinese Medicine formulas. Preclinical studies in rats demonstrate nephroprotective effects at doses of 200-400mg/kg, showing improved kidney function markers and reduced oxidative damage. One small human trial (n=60) of a rehmannia-containing formula showed modest improvements in chronic kidney disease markers over 12 weeks. The evidence base remains preliminary and requires larger, well-controlled human trials to establish clinical efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







